Age-related changes in hepatic expression and activity of drug metabolizing enzymes in male wild-type and breast cancer resistance protein knockout mice

Biopharmaceutics & Drug Disposition
Haihui ZhengZhongqiu Liu

Abstract

This study aimed to reveal age-related changes in the expression and activity of seven hepatic drug metabolizing enzymes (DMEs) in male wild-type and breast cancer resistance protein knockout (Bcrp1-/- ) FVB mice. The protein expression of four cytochrome P450 (Cyps) (Cyp3a11, 2d22, 2e1, and 1a2), and three UDP-glucuronosyltransferases (Ugts) (Ugt1a1, 1a6a, and 1a9) in liver microsomes of wild-type and Bcrp1-/- FVB mice at different ages were determined using a validated ultra high performance liquid chromatography with tandem mass spectrometry (UHPLC-MS/MS) method. The activities and mRNA levels of these DMEs were measured using the probe substrates method and real-time PCR, respectively. In the liver of wild-type FVB mice, Cyp3a11, 2d22, 2e1, 1a2, Ugt1a1, and 1a6a displayed maximum protein levels at 6-9 weeks of age. Cyp1a2, Ugt1a1, 1a6a, and 1a9 showed maximum activities at 6-9 weeks of age, whereas Cyp3a11, 2d22, and 2e1 showed maximum activities in 1-3-week-old mice. Additionally, most of the DMEs showed maximum mRNA levels in 17-week-old mice liver. Compared with wild-type FVB mice, the protein levels of these DMEs showed no significant changes in Bcrp1-/- FVB mice liver. However, the activity of Cyp2e1 was increased and ...Continue Reading

References

Apr 6, 1992·Biochimica Et Biophysica Acta·T YanagimotoT Kamataki
Mar 3, 2004·Molecular Interventions·F Peter Guengerich
Oct 20, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·David B Buckley, Curtis D Klaassen
Aug 8, 2009·British Journal of Clinical Pharmacology·Kosuke DokiYukinao Kohda
Nov 7, 2009·Molecular Pharmaceutics·K Sandy PangJianghong Fan
Dec 8, 2009·Molecular Pharmaceutics·Laurent Salphati
Feb 5, 2010·Archives of Toxicology·Kang Uk YunSang Kyum Kim
Apr 28, 2010·The Journal of Pharmacology and Experimental Therapeutics·Sagar AgarwalWilliam F Elmquist
Sep 10, 2011·Journal of Pharmaceutical Sciences·Baojian Wu
Aug 24, 2013·BioMed Research International·Erika VyskočilováIva Boušová
Jun 6, 2014·European Journal of Drug Metabolism and Pharmacokinetics·Atsushi KawaseMasahiro Iwaki
Jul 26, 2014·Archives of Pharmacal Research·Hui Chan KwakSang Kyum Kim
Mar 12, 2015·Drug Metabolism and Pharmacokinetics·Shingo OdaMiki Nakajima
Jun 9, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Yuting LiuLinlin Lu
Jan 1, 2015·Nuclear Receptor Research·Chandra PrakashBandana Chatterjee
Mar 31, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jiamei ChenZhongqiu Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.